TN SB 421
died on adjournmentOpioids - As enacted, clarifies that a physician licensed in this state is the only healthcare provider authorized to prescribe a buprenorphine product for a FDA-approved use in recovery or medication-assisted treatment; revises criteria for providers not licensed in this state to prescribe a buprenorphine product for the treatment of opioid use disorder. - Amends TCA Title 33; Title 41; Title 53 and Title 63.
Tennessee · 114S1 · upper
Subscribe in a feed reader. The feed covers recorded actions from the last 30 days; Bill Commons may record an action after it happened at the legislature.
Quick answers
Did TN SB 421 pass?
No. TN SB 421 died when the 114S1 session adjourned without final action on it. Bills that die this way are sometimes reintroduced in a later session. Latest recorded action (2025-04-28): Comp. became Pub. Ch. 295
What is TN SB 421 about?
TN SB 421 is a bill in the 114S1 titled “Opioids - As enacted, clarifies that a physician licensed in this state is the only healthcare provider authorized to prescribe a buprenorphine product for a FDA-approved use in recovery or medication-assisted treatment; revises criteria for providers not licensed in this state to prescribe a buprenorphine product for the treatment of opioid use disorder. - Amends TCA Title 33; Title 41; Title 53 and Title 63.”.
Who sponsors TN SB 421?
Reeves is the primary sponsor of TN SB 421.
- Introduced
- 2025-02-10
- Latest action
- 2025-04-28 — Comp. became Pub. Ch. 295
- Bill type
- bill
- Last updated
- —
Subjects
Sponsors
- Reevesprimary
Committees
Not provided by source.
Action timeline
Newest first
2025-04-28
Comp. became Pub. Ch. 295
2025-04-07
Companion House Bill substituted
substitution
2025-04-07
Sponsor(s) Added.
sponsorship
2025-04-04
Placed on Senate Regular Calendar for 4/7/2025
2025-04-03
Senate Reset on calendar for 4/7/2025
2025-04-01
Placed on Senate Regular Calendar for 4/3/2025
2025-03-31
Senate Reset on calendar for 4/3/2025
2025-03-31
Sponsor(s) Added.
sponsorship
2025-03-28
Placed on Senate Regular Calendar for 3/31/2025
2025-03-24
Senate Reset on calendar for 3/31/2025
2025-03-24
Sponsor(s) Added.
sponsorship
2025-03-21
Placed on Senate Regular Calendar for 3/24/2025
2025-03-17
Senate Reset on calendar for 3/27/2025
2025-03-14
Placed on Senate Regular Calendar for 3/17/2025
2025-03-11
Recommended for passage with amendment/s, refer to Senate Calendar Committee Ayes 9, Nays 0 PNV 0
2025-03-05
Placed on Senate Judiciary Committee calendar for 3/11/2025
2025-02-25
Action deferred in Senate Judiciary Committee to 3/11/2025
2025-02-19
Placed on Senate Judiciary Committee calendar for 2/25/2025
2025-02-12
Passed on Second Consideration, refer to Senate Judiciary Committee
referral-committee
2025-02-10
Introduced, Passed on First Consideration
introduction
2025-01-28
Filed for introduction
filing
Versions
Documents
- application/pdf(no extracted text yet)
- application/pdf(no extracted text yet)
- application/pdf(no extracted text yet)
- (no extracted text yet)
- (no extracted text yet)
- (no extracted text yet)
Votes
SENATE JUDICIARY COMMITTEE: Recommended for passage with amendment/s, refer to Senate Calendar Committee Ayes 9, Nays 0 PNV 0 3/11/2025 Passed
2025-03-11 · pass · 9-0
Related bills
- Companion bill: HB 1239
Official source
Attribution
Data from openstates_api_sync, retrieved 2026-10-27T20:15:31.985618Z
Inspect retained evidence for changes recorded after evidence tracking began:
Session-wide evidence can include changes to other bills:
Use this data
Every field on this page is available from the free public API — no key or licence required. Fetch this bill as JSON: GET /api/v1/bills?jurisdiction=TN&identifier=SB 421. See the API docs or the MCP server for AI assistants.
Known limitations
- Sponsor party and chamber affiliation are not yet captured by this API.
- Committee referrals are not yet captured.
- Some documents have no extracted text yet, so version comparison may be limited.
See the methodology page for data sources and limitations.